Ignite Creation Date:
2024-05-06 @ 8:49 AM
Last Modification Date:
2024-10-26 @ 12:05 PM
Study NCT ID:
NCT02823340
Status:
COMPLETED
Last Update Posted:
2021-03-15
First Post:
2016-06-16
Brief Title:
Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis
Sponsor:
Xijing Hospital
Organization:
Xijing Hospital
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Twenty patients with PAH had 1 session of Fractionated microneedle radiofrequency treatment Clinical improvement was evaluated using a Hyperhidrosis Disease Severity Scale HDSS and photographs were taken using the starch-iodine test at every visit and 4 weeks 8 weeks and 24 weeks after the treatment Skin biopsies were obtained from 3 of the enrolled patients before and after treatment The satisfaction and adverse reactions of the research participants were recorded at every follow-up visit
Detailed Description:
Hyperhidrosis Disease Severity Scale HDSSScore 1 My sweating is never noticeable and never interferes with my daily activitiesScore 2 My sweating is tolerable but sometimes interferes with my daily activitiesScore 3 My sweating is barely tolerable and frequently interferes with my daily activitiesScore 4 My sweating is intolerable and always interferes with my daily activities
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None